2024-20895. Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Clozapine Test System
Table 1—Clozapine Test System Risks and Mitigation Measures
Identified risks to health Mitigation measures Incorrect test results Certain design verification and validation activities and Certain labeling information. ( print page 75491) Incorrect interpretation of test results Certain design verification and validation activities and Certain labeling information.
Document Information
- Effective Date:
- 9/16/2024
- Published:
- 09/16/2024
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Action:
- Final amendment; final order.
- Document Number:
- 2024-20895
- Dates:
- This order is effective September 16, 2024. The classification was applicable on April 16, 2020.
- Pages:
- 75489-75491 (3 pages)
- Docket Numbers:
- Docket No. FDA-2024-N-4058
- Topics:
- Medical devices
- PDF File:
- 2024-20895.pdf
- CFR: (1)
- 21 CFR 862